Loading…
Activation of Mst1 causes dilated cardiomyopathy by stimulating apoptosis without compensatory ventricular myocyte hypertrophy
Activation of mammalian sterile 20-like kinase 1 (Mst1) by genotoxic compounds is known to stimulate apoptosis in some cell types. The importance of Mst1 in cell death caused by clinically relevant pathologic stimuli is unknown, however. In this study, we show that Mst1 is a prominent myelin basic p...
Saved in:
Published in: | The Journal of clinical investigation 2003-05, Vol.111 (10), p.1463-1474 |
---|---|
Main Authors: | , , , , , , , , , , , , , , |
Format: | Article |
Language: | English |
Subjects: | |
Citations: | Items that this one cites Items that cite this one |
Online Access: | Get full text |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
cited_by | cdi_FETCH-LOGICAL-c4309-f01c012216691c6d06e263cd78f0394cf3d7c225f76fdfc18f6c374cac9c8df43 |
---|---|
cites | cdi_FETCH-LOGICAL-c4309-f01c012216691c6d06e263cd78f0394cf3d7c225f76fdfc18f6c374cac9c8df43 |
container_end_page | 1474 |
container_issue | 10 |
container_start_page | 1463 |
container_title | The Journal of clinical investigation |
container_volume | 111 |
creator | Yamamoto, Shimako Yang, Guiping Zablocki, Daniela Liu, Jing Hong, Chull Kim, Song-Jung Soler, Sandra Odashima, Mari Thaisz, Jill Yehia, Ghassan Molina, Carlos A Yatani, Atsuko Vatner, Dorothy E Vatner, Stephen F Sadoshima, Junichi |
description | Activation of mammalian sterile 20-like kinase 1 (Mst1) by genotoxic compounds is known to stimulate apoptosis in some cell types. The importance of Mst1 in cell death caused by clinically relevant pathologic stimuli is unknown, however. In this study, we show that Mst1 is a prominent myelin basic protein kinase activated by proapoptotic stimuli in cardiac myocytes and that Mst1 causes cardiac myocyte apoptosis in vitro in a kinase activity-dependent manner. In vivo, cardiac-specific overexpression of Mst1 in transgenic mice results in activation of caspases, increased apoptosis, and dilated cardiomyopathy. Surprisingly, however, Mst1 prevents compensatory cardiac myocyte elongation or hypertrophy despite increased wall stress, thereby obscuring the use of the Frank-Starling mechanism, a fundamental mechanism by which the heart maintains cardiac output in response to increased mechanical load at the single myocyte level. Furthermore, Mst1 is activated by ischemia/reperfusion in the mouse heart in vivo. Suppression of endogenous Mst1 by cardiac-specific overexpression of dominant-negative Mst1 in transgenic mice prevents myocyte death by pathologic insults. These results show that Mst1 works as both an essential initiator of apoptosis and an inhibitor of hypertrophy in cardiac myocytes, resulting in a previously unrecognized form of cardiomyopathy. |
doi_str_mv | 10.1172/jci17459 |
format | article |
fullrecord | <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_journals_200525347</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>354385661</sourcerecordid><originalsourceid>FETCH-LOGICAL-c4309-f01c012216691c6d06e263cd78f0394cf3d7c225f76fdfc18f6c374cac9c8df43</originalsourceid><addsrcrecordid>eNpFkE1LxDAQhoMouq6Cv0CCJy_VfLVpj8viJ4oXPZfsJLFZbFOTdKUXf7vVXfA0vMzDO8yD0BklV5RKdr0GR6XIqz00o3leZiXj5T6aEcJoVkleHqHjGNeEUCFycYiOKJM54VUxQ98LSG6jkvMd9hY_x0QxqCGaiLX7UMnoKQbtfDv6XqVmxKsRx-TaYVq67h2r3vfJRxfxl0uNHxIG3_amiyr5MOKN6VJwMNEBTxUwJoObsTchBd834wk6sOojmtPdnKO325vX5X329HL3sFw8ZSA4qTJLKBDKGC2KikKhSWFYwUHL0k5vCLBcS2Ast7Kw2gItbQFcClBQQamt4HN0se3tg_8cTEz12g-hm07WjJCc5VzICbrcQhB8jMHYug-uVWGsKal_PdePy4c_zxN6vusbVq3R_-BOLP8BtiZ7yw</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>200525347</pqid></control><display><type>article</type><title>Activation of Mst1 causes dilated cardiomyopathy by stimulating apoptosis without compensatory ventricular myocyte hypertrophy</title><source>NCBI_PubMed Central(免费)</source><source>EZB Electronic Journals Library</source><creator>Yamamoto, Shimako ; Yang, Guiping ; Zablocki, Daniela ; Liu, Jing ; Hong, Chull ; Kim, Song-Jung ; Soler, Sandra ; Odashima, Mari ; Thaisz, Jill ; Yehia, Ghassan ; Molina, Carlos A ; Yatani, Atsuko ; Vatner, Dorothy E ; Vatner, Stephen F ; Sadoshima, Junichi</creator><creatorcontrib>Yamamoto, Shimako ; Yang, Guiping ; Zablocki, Daniela ; Liu, Jing ; Hong, Chull ; Kim, Song-Jung ; Soler, Sandra ; Odashima, Mari ; Thaisz, Jill ; Yehia, Ghassan ; Molina, Carlos A ; Yatani, Atsuko ; Vatner, Dorothy E ; Vatner, Stephen F ; Sadoshima, Junichi</creatorcontrib><description>Activation of mammalian sterile 20-like kinase 1 (Mst1) by genotoxic compounds is known to stimulate apoptosis in some cell types. The importance of Mst1 in cell death caused by clinically relevant pathologic stimuli is unknown, however. In this study, we show that Mst1 is a prominent myelin basic protein kinase activated by proapoptotic stimuli in cardiac myocytes and that Mst1 causes cardiac myocyte apoptosis in vitro in a kinase activity-dependent manner. In vivo, cardiac-specific overexpression of Mst1 in transgenic mice results in activation of caspases, increased apoptosis, and dilated cardiomyopathy. Surprisingly, however, Mst1 prevents compensatory cardiac myocyte elongation or hypertrophy despite increased wall stress, thereby obscuring the use of the Frank-Starling mechanism, a fundamental mechanism by which the heart maintains cardiac output in response to increased mechanical load at the single myocyte level. Furthermore, Mst1 is activated by ischemia/reperfusion in the mouse heart in vivo. Suppression of endogenous Mst1 by cardiac-specific overexpression of dominant-negative Mst1 in transgenic mice prevents myocyte death by pathologic insults. These results show that Mst1 works as both an essential initiator of apoptosis and an inhibitor of hypertrophy in cardiac myocytes, resulting in a previously unrecognized form of cardiomyopathy.</description><identifier>ISSN: 0021-9738</identifier><identifier>EISSN: 1558-8238</identifier><identifier>DOI: 10.1172/jci17459</identifier><identifier>PMID: 12750396</identifier><language>eng</language><publisher>United States: American Society for Clinical Investigation</publisher><subject>Adenoviruses ; Alkaloids ; Animals ; Apoptosis ; Apoptosis - drug effects ; Benzophenanthridines ; Biomedical research ; Cardiomegaly - etiology ; Cardiomegaly - pathology ; Cardiomyopathy ; Cardiomyopathy, Dilated - etiology ; Cardiomyopathy, Dilated - pathology ; Cardiomyopathy, Dilated - physiopathology ; Cardiovascular disease ; Caspase 3 ; Caspases - metabolism ; Cell death ; Cells, Cultured ; Cytochrome ; Enzyme Activation - drug effects ; Enzyme Inhibitors - pharmacology ; Genes, Dominant ; Heart attacks ; Heart failure ; Heart Ventricles - pathology ; Ischemia ; Kinases ; Laboratories ; Mice ; Mice, Transgenic ; Myocardial Ischemia - genetics ; Myocardial Ischemia - metabolism ; Myocardial Ischemia - pathology ; Myocardial Reperfusion Injury - genetics ; Myocardial Reperfusion Injury - metabolism ; Myocardial Reperfusion Injury - pathology ; Myocardium - metabolism ; Myocardium - pathology ; Myocytes, Cardiac - drug effects ; Myocytes, Cardiac - metabolism ; Myocytes, Cardiac - pathology ; Organ Specificity ; Oxazoles - pharmacology ; Phenanthridines - pharmacology ; Protein-Serine-Threonine Kinases - genetics ; Protein-Serine-Threonine Kinases - metabolism ; Proteins ; Rats ; Rats, Wistar ; Transduction, Genetic ; Transgenic animals</subject><ispartof>The Journal of clinical investigation, 2003-05, Vol.111 (10), p.1463-1474</ispartof><rights>Copyright American Society for Clinical Investigation May 2003</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c4309-f01c012216691c6d06e263cd78f0394cf3d7c225f76fdfc18f6c374cac9c8df43</citedby><cites>FETCH-LOGICAL-c4309-f01c012216691c6d06e263cd78f0394cf3d7c225f76fdfc18f6c374cac9c8df43</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,780,784,27924,27925</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/12750396$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Yamamoto, Shimako</creatorcontrib><creatorcontrib>Yang, Guiping</creatorcontrib><creatorcontrib>Zablocki, Daniela</creatorcontrib><creatorcontrib>Liu, Jing</creatorcontrib><creatorcontrib>Hong, Chull</creatorcontrib><creatorcontrib>Kim, Song-Jung</creatorcontrib><creatorcontrib>Soler, Sandra</creatorcontrib><creatorcontrib>Odashima, Mari</creatorcontrib><creatorcontrib>Thaisz, Jill</creatorcontrib><creatorcontrib>Yehia, Ghassan</creatorcontrib><creatorcontrib>Molina, Carlos A</creatorcontrib><creatorcontrib>Yatani, Atsuko</creatorcontrib><creatorcontrib>Vatner, Dorothy E</creatorcontrib><creatorcontrib>Vatner, Stephen F</creatorcontrib><creatorcontrib>Sadoshima, Junichi</creatorcontrib><title>Activation of Mst1 causes dilated cardiomyopathy by stimulating apoptosis without compensatory ventricular myocyte hypertrophy</title><title>The Journal of clinical investigation</title><addtitle>J Clin Invest</addtitle><description>Activation of mammalian sterile 20-like kinase 1 (Mst1) by genotoxic compounds is known to stimulate apoptosis in some cell types. The importance of Mst1 in cell death caused by clinically relevant pathologic stimuli is unknown, however. In this study, we show that Mst1 is a prominent myelin basic protein kinase activated by proapoptotic stimuli in cardiac myocytes and that Mst1 causes cardiac myocyte apoptosis in vitro in a kinase activity-dependent manner. In vivo, cardiac-specific overexpression of Mst1 in transgenic mice results in activation of caspases, increased apoptosis, and dilated cardiomyopathy. Surprisingly, however, Mst1 prevents compensatory cardiac myocyte elongation or hypertrophy despite increased wall stress, thereby obscuring the use of the Frank-Starling mechanism, a fundamental mechanism by which the heart maintains cardiac output in response to increased mechanical load at the single myocyte level. Furthermore, Mst1 is activated by ischemia/reperfusion in the mouse heart in vivo. Suppression of endogenous Mst1 by cardiac-specific overexpression of dominant-negative Mst1 in transgenic mice prevents myocyte death by pathologic insults. These results show that Mst1 works as both an essential initiator of apoptosis and an inhibitor of hypertrophy in cardiac myocytes, resulting in a previously unrecognized form of cardiomyopathy.</description><subject>Adenoviruses</subject><subject>Alkaloids</subject><subject>Animals</subject><subject>Apoptosis</subject><subject>Apoptosis - drug effects</subject><subject>Benzophenanthridines</subject><subject>Biomedical research</subject><subject>Cardiomegaly - etiology</subject><subject>Cardiomegaly - pathology</subject><subject>Cardiomyopathy</subject><subject>Cardiomyopathy, Dilated - etiology</subject><subject>Cardiomyopathy, Dilated - pathology</subject><subject>Cardiomyopathy, Dilated - physiopathology</subject><subject>Cardiovascular disease</subject><subject>Caspase 3</subject><subject>Caspases - metabolism</subject><subject>Cell death</subject><subject>Cells, Cultured</subject><subject>Cytochrome</subject><subject>Enzyme Activation - drug effects</subject><subject>Enzyme Inhibitors - pharmacology</subject><subject>Genes, Dominant</subject><subject>Heart attacks</subject><subject>Heart failure</subject><subject>Heart Ventricles - pathology</subject><subject>Ischemia</subject><subject>Kinases</subject><subject>Laboratories</subject><subject>Mice</subject><subject>Mice, Transgenic</subject><subject>Myocardial Ischemia - genetics</subject><subject>Myocardial Ischemia - metabolism</subject><subject>Myocardial Ischemia - pathology</subject><subject>Myocardial Reperfusion Injury - genetics</subject><subject>Myocardial Reperfusion Injury - metabolism</subject><subject>Myocardial Reperfusion Injury - pathology</subject><subject>Myocardium - metabolism</subject><subject>Myocardium - pathology</subject><subject>Myocytes, Cardiac - drug effects</subject><subject>Myocytes, Cardiac - metabolism</subject><subject>Myocytes, Cardiac - pathology</subject><subject>Organ Specificity</subject><subject>Oxazoles - pharmacology</subject><subject>Phenanthridines - pharmacology</subject><subject>Protein-Serine-Threonine Kinases - genetics</subject><subject>Protein-Serine-Threonine Kinases - metabolism</subject><subject>Proteins</subject><subject>Rats</subject><subject>Rats, Wistar</subject><subject>Transduction, Genetic</subject><subject>Transgenic animals</subject><issn>0021-9738</issn><issn>1558-8238</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2003</creationdate><recordtype>article</recordtype><recordid>eNpFkE1LxDAQhoMouq6Cv0CCJy_VfLVpj8viJ4oXPZfsJLFZbFOTdKUXf7vVXfA0vMzDO8yD0BklV5RKdr0GR6XIqz00o3leZiXj5T6aEcJoVkleHqHjGNeEUCFycYiOKJM54VUxQ98LSG6jkvMd9hY_x0QxqCGaiLX7UMnoKQbtfDv6XqVmxKsRx-TaYVq67h2r3vfJRxfxl0uNHxIG3_amiyr5MOKN6VJwMNEBTxUwJoObsTchBd834wk6sOojmtPdnKO325vX5X329HL3sFw8ZSA4qTJLKBDKGC2KikKhSWFYwUHL0k5vCLBcS2Ast7Kw2gItbQFcClBQQamt4HN0se3tg_8cTEz12g-hm07WjJCc5VzICbrcQhB8jMHYug-uVWGsKal_PdePy4c_zxN6vusbVq3R_-BOLP8BtiZ7yw</recordid><startdate>200305</startdate><enddate>200305</enddate><creator>Yamamoto, Shimako</creator><creator>Yang, Guiping</creator><creator>Zablocki, Daniela</creator><creator>Liu, Jing</creator><creator>Hong, Chull</creator><creator>Kim, Song-Jung</creator><creator>Soler, Sandra</creator><creator>Odashima, Mari</creator><creator>Thaisz, Jill</creator><creator>Yehia, Ghassan</creator><creator>Molina, Carlos A</creator><creator>Yatani, Atsuko</creator><creator>Vatner, Dorothy E</creator><creator>Vatner, Stephen F</creator><creator>Sadoshima, Junichi</creator><general>American Society for Clinical Investigation</general><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>3V.</scope><scope>7RV</scope><scope>7X7</scope><scope>7XB</scope><scope>88A</scope><scope>88E</scope><scope>8AO</scope><scope>8FE</scope><scope>8FH</scope><scope>8FI</scope><scope>8FJ</scope><scope>8FK</scope><scope>ABUWG</scope><scope>AFKRA</scope><scope>AZQEC</scope><scope>BBNVY</scope><scope>BEC</scope><scope>BENPR</scope><scope>BHPHI</scope><scope>CCPQU</scope><scope>DWQXO</scope><scope>FYUFA</scope><scope>GHDGH</scope><scope>GNUQQ</scope><scope>HCIFZ</scope><scope>K9.</scope><scope>KB0</scope><scope>LK8</scope><scope>M0S</scope><scope>M1P</scope><scope>M7P</scope><scope>NAPCQ</scope><scope>PQEST</scope><scope>PQQKQ</scope><scope>PQUKI</scope><scope>S0X</scope></search><sort><creationdate>200305</creationdate><title>Activation of Mst1 causes dilated cardiomyopathy by stimulating apoptosis without compensatory ventricular myocyte hypertrophy</title><author>Yamamoto, Shimako ; Yang, Guiping ; Zablocki, Daniela ; Liu, Jing ; Hong, Chull ; Kim, Song-Jung ; Soler, Sandra ; Odashima, Mari ; Thaisz, Jill ; Yehia, Ghassan ; Molina, Carlos A ; Yatani, Atsuko ; Vatner, Dorothy E ; Vatner, Stephen F ; Sadoshima, Junichi</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c4309-f01c012216691c6d06e263cd78f0394cf3d7c225f76fdfc18f6c374cac9c8df43</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2003</creationdate><topic>Adenoviruses</topic><topic>Alkaloids</topic><topic>Animals</topic><topic>Apoptosis</topic><topic>Apoptosis - drug effects</topic><topic>Benzophenanthridines</topic><topic>Biomedical research</topic><topic>Cardiomegaly - etiology</topic><topic>Cardiomegaly - pathology</topic><topic>Cardiomyopathy</topic><topic>Cardiomyopathy, Dilated - etiology</topic><topic>Cardiomyopathy, Dilated - pathology</topic><topic>Cardiomyopathy, Dilated - physiopathology</topic><topic>Cardiovascular disease</topic><topic>Caspase 3</topic><topic>Caspases - metabolism</topic><topic>Cell death</topic><topic>Cells, Cultured</topic><topic>Cytochrome</topic><topic>Enzyme Activation - drug effects</topic><topic>Enzyme Inhibitors - pharmacology</topic><topic>Genes, Dominant</topic><topic>Heart attacks</topic><topic>Heart failure</topic><topic>Heart Ventricles - pathology</topic><topic>Ischemia</topic><topic>Kinases</topic><topic>Laboratories</topic><topic>Mice</topic><topic>Mice, Transgenic</topic><topic>Myocardial Ischemia - genetics</topic><topic>Myocardial Ischemia - metabolism</topic><topic>Myocardial Ischemia - pathology</topic><topic>Myocardial Reperfusion Injury - genetics</topic><topic>Myocardial Reperfusion Injury - metabolism</topic><topic>Myocardial Reperfusion Injury - pathology</topic><topic>Myocardium - metabolism</topic><topic>Myocardium - pathology</topic><topic>Myocytes, Cardiac - drug effects</topic><topic>Myocytes, Cardiac - metabolism</topic><topic>Myocytes, Cardiac - pathology</topic><topic>Organ Specificity</topic><topic>Oxazoles - pharmacology</topic><topic>Phenanthridines - pharmacology</topic><topic>Protein-Serine-Threonine Kinases - genetics</topic><topic>Protein-Serine-Threonine Kinases - metabolism</topic><topic>Proteins</topic><topic>Rats</topic><topic>Rats, Wistar</topic><topic>Transduction, Genetic</topic><topic>Transgenic animals</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Yamamoto, Shimako</creatorcontrib><creatorcontrib>Yang, Guiping</creatorcontrib><creatorcontrib>Zablocki, Daniela</creatorcontrib><creatorcontrib>Liu, Jing</creatorcontrib><creatorcontrib>Hong, Chull</creatorcontrib><creatorcontrib>Kim, Song-Jung</creatorcontrib><creatorcontrib>Soler, Sandra</creatorcontrib><creatorcontrib>Odashima, Mari</creatorcontrib><creatorcontrib>Thaisz, Jill</creatorcontrib><creatorcontrib>Yehia, Ghassan</creatorcontrib><creatorcontrib>Molina, Carlos A</creatorcontrib><creatorcontrib>Yatani, Atsuko</creatorcontrib><creatorcontrib>Vatner, Dorothy E</creatorcontrib><creatorcontrib>Vatner, Stephen F</creatorcontrib><creatorcontrib>Sadoshima, Junichi</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>ProQuest Central (Corporate)</collection><collection>ProQuest Nursing and Allied Health Source</collection><collection>ProQuest_Health & Medical Collection</collection><collection>ProQuest Central (purchase pre-March 2016)</collection><collection>Biology Database (Alumni Edition)</collection><collection>Medical Database (Alumni Edition)</collection><collection>ProQuest Pharma Collection</collection><collection>ProQuest SciTech Collection</collection><collection>ProQuest Natural Science Collection</collection><collection>Hospital Premium Collection</collection><collection>Hospital Premium Collection (Alumni Edition)</collection><collection>ProQuest Central (Alumni) (purchase pre-March 2016)</collection><collection>ProQuest Central (Alumni)</collection><collection>ProQuest Central UK/Ireland</collection><collection>ProQuest Central Essentials</collection><collection>Biological Science Collection</collection><collection>eLibrary</collection><collection>AUTh Library subscriptions: ProQuest Central</collection><collection>ProQuest Natural Science Collection</collection><collection>ProQuest One Community College</collection><collection>ProQuest Central</collection><collection>Health Research Premium Collection</collection><collection>Health Research Premium Collection (Alumni)</collection><collection>ProQuest Central Student</collection><collection>SciTech Premium Collection</collection><collection>ProQuest Health & Medical Complete (Alumni)</collection><collection>Nursing & Allied Health Database (Alumni Edition)</collection><collection>ProQuest Biological Science Collection</collection><collection>Health & Medical Collection (Alumni Edition)</collection><collection>Medical Database</collection><collection>ProQuest Biological Science Journals</collection><collection>Nursing & Allied Health Premium</collection><collection>ProQuest One Academic Eastern Edition (DO NOT USE)</collection><collection>ProQuest One Academic</collection><collection>ProQuest One Academic UKI Edition</collection><collection>SIRS Editorial</collection><jtitle>The Journal of clinical investigation</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Yamamoto, Shimako</au><au>Yang, Guiping</au><au>Zablocki, Daniela</au><au>Liu, Jing</au><au>Hong, Chull</au><au>Kim, Song-Jung</au><au>Soler, Sandra</au><au>Odashima, Mari</au><au>Thaisz, Jill</au><au>Yehia, Ghassan</au><au>Molina, Carlos A</au><au>Yatani, Atsuko</au><au>Vatner, Dorothy E</au><au>Vatner, Stephen F</au><au>Sadoshima, Junichi</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Activation of Mst1 causes dilated cardiomyopathy by stimulating apoptosis without compensatory ventricular myocyte hypertrophy</atitle><jtitle>The Journal of clinical investigation</jtitle><addtitle>J Clin Invest</addtitle><date>2003-05</date><risdate>2003</risdate><volume>111</volume><issue>10</issue><spage>1463</spage><epage>1474</epage><pages>1463-1474</pages><issn>0021-9738</issn><eissn>1558-8238</eissn><abstract>Activation of mammalian sterile 20-like kinase 1 (Mst1) by genotoxic compounds is known to stimulate apoptosis in some cell types. The importance of Mst1 in cell death caused by clinically relevant pathologic stimuli is unknown, however. In this study, we show that Mst1 is a prominent myelin basic protein kinase activated by proapoptotic stimuli in cardiac myocytes and that Mst1 causes cardiac myocyte apoptosis in vitro in a kinase activity-dependent manner. In vivo, cardiac-specific overexpression of Mst1 in transgenic mice results in activation of caspases, increased apoptosis, and dilated cardiomyopathy. Surprisingly, however, Mst1 prevents compensatory cardiac myocyte elongation or hypertrophy despite increased wall stress, thereby obscuring the use of the Frank-Starling mechanism, a fundamental mechanism by which the heart maintains cardiac output in response to increased mechanical load at the single myocyte level. Furthermore, Mst1 is activated by ischemia/reperfusion in the mouse heart in vivo. Suppression of endogenous Mst1 by cardiac-specific overexpression of dominant-negative Mst1 in transgenic mice prevents myocyte death by pathologic insults. These results show that Mst1 works as both an essential initiator of apoptosis and an inhibitor of hypertrophy in cardiac myocytes, resulting in a previously unrecognized form of cardiomyopathy.</abstract><cop>United States</cop><pub>American Society for Clinical Investigation</pub><pmid>12750396</pmid><doi>10.1172/jci17459</doi><tpages>12</tpages><oa>free_for_read</oa></addata></record> |
fulltext | fulltext |
identifier | ISSN: 0021-9738 |
ispartof | The Journal of clinical investigation, 2003-05, Vol.111 (10), p.1463-1474 |
issn | 0021-9738 1558-8238 |
language | eng |
recordid | cdi_proquest_journals_200525347 |
source | NCBI_PubMed Central(免费); EZB Electronic Journals Library |
subjects | Adenoviruses Alkaloids Animals Apoptosis Apoptosis - drug effects Benzophenanthridines Biomedical research Cardiomegaly - etiology Cardiomegaly - pathology Cardiomyopathy Cardiomyopathy, Dilated - etiology Cardiomyopathy, Dilated - pathology Cardiomyopathy, Dilated - physiopathology Cardiovascular disease Caspase 3 Caspases - metabolism Cell death Cells, Cultured Cytochrome Enzyme Activation - drug effects Enzyme Inhibitors - pharmacology Genes, Dominant Heart attacks Heart failure Heart Ventricles - pathology Ischemia Kinases Laboratories Mice Mice, Transgenic Myocardial Ischemia - genetics Myocardial Ischemia - metabolism Myocardial Ischemia - pathology Myocardial Reperfusion Injury - genetics Myocardial Reperfusion Injury - metabolism Myocardial Reperfusion Injury - pathology Myocardium - metabolism Myocardium - pathology Myocytes, Cardiac - drug effects Myocytes, Cardiac - metabolism Myocytes, Cardiac - pathology Organ Specificity Oxazoles - pharmacology Phenanthridines - pharmacology Protein-Serine-Threonine Kinases - genetics Protein-Serine-Threonine Kinases - metabolism Proteins Rats Rats, Wistar Transduction, Genetic Transgenic animals |
title | Activation of Mst1 causes dilated cardiomyopathy by stimulating apoptosis without compensatory ventricular myocyte hypertrophy |
url | http://sfxeu10.hosted.exlibrisgroup.com/loughborough?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2024-12-28T10%3A12%3A07IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Activation%20of%20Mst1%20causes%20dilated%20cardiomyopathy%20by%20stimulating%20apoptosis%20without%20compensatory%20ventricular%20myocyte%20hypertrophy&rft.jtitle=The%20Journal%20of%20clinical%20investigation&rft.au=Yamamoto,%20Shimako&rft.date=2003-05&rft.volume=111&rft.issue=10&rft.spage=1463&rft.epage=1474&rft.pages=1463-1474&rft.issn=0021-9738&rft.eissn=1558-8238&rft_id=info:doi/10.1172/jci17459&rft_dat=%3Cproquest_cross%3E354385661%3C/proquest_cross%3E%3Cgrp_id%3Ecdi_FETCH-LOGICAL-c4309-f01c012216691c6d06e263cd78f0394cf3d7c225f76fdfc18f6c374cac9c8df43%3C/grp_id%3E%3Coa%3E%3C/oa%3E%3Curl%3E%3C/url%3E&rft_id=info:oai/&rft_pqid=200525347&rft_id=info:pmid/12750396&rfr_iscdi=true |